Fig. 5: Therapeutic strategies for targeting EMT.

There are three main strategies for targeted EMT treatment: I) inhibiting tumorigenesis by blocking upstream signaling pathways, II) targeting the molecular drivers of EMT, and III) targeting mesenchymal markers or inhibiting the MET process.